Trump’s tariffs could raise the cost of generic drugs in the U.S.

President-elect Donald Trump’s proposed tariffs on Chinese and foreign products could lead to increased costs for generic drugs in the U.S., as most are manufactured overseas. The tariffs may result in higher prices for patients, exacerbate drug shortages, and fail to encourage domestic drug manufacturing due to low profit margins. The potential impact on brand-name drugs is minimal compared to the significant effect on generic drug prices.

Full Article